Head of Analytical Sciences, Biologics Development— 恒瑞-全球精英计划 – Hengrui Pharma – Jobs in Princeton, NJ | OpenJobs AI

Job Details

Overview Company

Head of Analytical Sciences, Biologics Development— 恒瑞-全球精英计划

Hengrui Pharma

2 days ago

Highlight

OnsiteFull-timeDirector

Summary

Hengrui Pharma is seeking a Head of Analytical Sciences, Biologics Development to join their team in Shanghai. The role involves overseeing analytical method development, qualification, validation, transfer, and quality control testing for biologics.

About the Role

As the Head of Analytical Sciences, you will lead the Analytical Science function for Biologics, covering method development, method transfer, validation, and QC testing. You will oversee the design and execution of analytical methods to support drug development, direct stability studies, and ensure compliance with regulatory requirements. Additionally, you will build and lead a high-performing team, collaborate with cross-functional teams, participate in regulatory submissions, and manage departmental budgets.

About You

Required:

PhD in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, or a related discipline.
10+ years of experience in analytical development and quality control for biologics within the biopharmaceutical industry.
Proven leadership and management experience in a Good Manufacturing Practice (GMP)-regulated environment.
Deep technical expertise in analytical techniques used for biologics characterization and release.
Strong understanding of regulatory expectations for biologics at all stages of development.
Experience authoring regulatory submissions and interacting with health authorities (e.g., NMPA, FDA, EMA).
Excellent problem-solving, communication, and organizational skills.
Fluent in both Mandarin and English.

Preferred:

Strategic thinker with a hands-on, collaborative approach to team leadership.

Hengrui Pharma

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. With a global R&D team that includes 14 R&D centers and more than 5,500 professionals, Hengrui Pharma’s therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. To date, Hengrui has commercialized 19 new molecular entity drugs and 4 other innovative drugs in China. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology.

Princeton, NJ